Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Columnist Ahna Crum, who's a practitioner in functional medicine, questioned herself when she had an unexpected MS relapse.

Fumarate therapies are equally effective among Black, Hispanic, Asian, and white people with relapsing forms of MS, a real-world study shows.

Regular exercise that follows established guidelines for physical activity in MS lead to clinically meaningful improvements ...

An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...

A person's total number of visits to multiple sclerosis clinics is not associated with a lower risk of death, a study on ...

A six-week music-based intervention may reduce psychosocial fatigue and heat pain sensitivity in people with multiple ...

Mesenchymal stem cell therapy lessens disability and brain lesions in MS patients, according to a review of published studies ...

Vibration therapy eases fatigue and improves motor and cognitive outcomes in MS, outperforming standard physical exercise ...

GFAP, or glial fibrillary acidic protein, supports star-shaped brain cells called astrocytes that help maintain nerve cell ...

Neural stem cell treatment was safe and significantly boosted myelin repair in spinal cord lesions in a mouse model of MS, ...

People with MS visited doctors, were hospitalized, and used emergency care more than other people decades before their ...